Compositions and methods involving staphylococcus aureus protein STAAUR9

Details for Australian Patent Application No. 2002226212 (hide)

International Classifications

Event Publications

21 April 2005 Change of Name(s) of Applicant(s), Section 104

PhageTech Inc. The name of the applicant has been changed to Targanta Therapeutics Inc.

16 November 2006 Application Accepted

Published as AU-B-2002226212

15 February 2007 Application for Amendment

The nature of the amendment is: Add co-inventor Bergeron Dominique. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000

24 May 2007 Amendment Made

The nature of the amendment is: Add co-inventor Bergeron, Dominique

24 May 2007 Standard Patent Sealed

17 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.